<DOC>
	<DOCNO>NCT00874146</DOCNO>
	<brief_summary>Primary objective study evaluate correlation level HER2-neu gene amplification evalued dual-color Fluorescent in-situ hybridization ( FISH ) test time progression ( TTP ) patient HER2-positive advanced breast cancer treat trastuzumab-containing regimen .</brief_summary>
	<brief_title>Level HER2-neu Gene Amplification Response Trastuzumab</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>HER2positive breast cancer Trastuzumabcontaining regimen deliver advanced disease Tumor sample available Pathology Archive HER2negative advance breast cancer Pretreatment trastuzumab</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2010</verification_date>
</DOC>